I wanted to provide you an update on the 17th installment of the Precision Medicine World Conference, taking place January 21-24, 2020. PMWC – The Premiere Precision Medicine Conference has doubled in size and will fill the entire Santa Clara Convention Center, co-hosted by Stanford Health Care, UCSF, Duke Health, Duke University, University of Pittsburgh, and the University of Michigan.

New at PMWC:
– 7 Tracks (5 main tracks + 2 showcase tracks)
– 80+ exhibits clustered by theme with double the space for attendees and exhibition on one floor
– 2500+ multidisciplinary stakeholders attending from across the medical, academic, government, investment, regulatory, and technology sectors and around the globe
– Award Reception that recognizes leaders who accelerated precision medicine, held at UCSF Mission Bay
– 400+ Renowned Speakers
– 130 Showcase Presenters – novel products, late-breaking research data, and innovative projects
– Venue ~5 miles from San Jose Airport (SJC), connected to the Hyatt hotel for convenient travel

Register Here for the Best Rates by December 12

Track Highlights:

• Emerging Therapeutics (Track 1) with sessions that focus on various aspects of cancer immunotherapy, cardiovascular disease, and rare genetic diseases. Sessions include CAR-T Cell Therapy, Cancer Neoantigen Vaccines, Cardiovascular disease genetics and proteomics, Cardiovascular imaging. Cardiomyopathy therapeutics, SMA, SCID and Batten therapeutics, CRISPR, and the FDA Perspective
– Chaired by Dr. Theresa LaVallee, VP Translational Medicine and Regulatory Affairs at the Parker Institute for Cancer Immunotherapy

• AI/ML Data Science (Track 2) with sessions that focus on various aspects of artificial intelligence, machine learning, deep learning and data science in healthcare, including Data Science in Drug Discovery, Clinical Trial Design and Patient Selection, Data Mining and Visualization, and Driving Towards Value-Based Care
– Chaired by Dr. Stanley Huff, Chief Medical Informatics Officer at Intermountain Healthcare

• Diagnostics in Clinical Practice (Track 3) addressing various genomics advancements, applications, and challenges in the clinical setting, including Liquid Biopsy Applications, Sequencing Data Challenges, Supporting Technologies, Women’s Health, Clinical Dx/NIPT, and Rare Disease Dx
– Chaired by Dr. Aleksander Rajkovic, Chief Genomics Officer at UCSF Health

• Molecular Profiling – From Research to the Clinic (Track 4) designed to provide insight into the innovative approaches and progress that is being made to address the technological challenges and achieve the vision of a learning healthcare system, including Adoption of Molecular Profiling in the Clinical Setting, Molecular Tumor Boards, NGS Workflows for Clinical Diagnostics Applications, Navigating Secondary Use of Genomics Data, DTC DNA Reporting, Risk Profiling, and Regulatory & Reimbursement Risk/Reward in Clinical CDx
– Chaired by Chris Cournoyer, former CEO of N-of-One, now strategic advisor to QIAGEN

• Health Data / Microbiome / Patient Education (Track 5) touches upon the importance of health data with a focus on Making Precision Medicine Mainstream With Health Data, The Physician and Patient Perspective, Chronic Diseases, and more. In addition, much of the track is dedicated to exploring advances and opportunities in microbiome science, including Microbiome-Based Precision Medicine: State of the Science, Clinical Applications of Microbiome in Cancer, The Gut Microbiome and Cardiovascular Diseases, Microbiome-Based Tx & Dx, and Investment in the Microbiome
– Chaired by Dr. Michael Snyder, Professor & Chair, Stanford Center of Genomics & Personalized Medicine

See the Full Program, Speakers and Sessions

Key opinion leaders and decision-makers attending and presenting:
• Philip Greenberg, Fred Hutch
• Steve Shak, Genomic Health
• Brook Byers, Kleiner Perkins
• Mary V. Relling, St. Jude Children’s Research Hospital
• Stan Huff, Intermountain Healthcare
• Atul Butte, UCSF
• Mike Snyder, Stanford
• Sean Khozin, FDA
• Thomas Hawes, Blue Cross Blue Shield Ventures
• Laura van’t Veer, UCSF
• Ira Mellman, Genentech
• Theresa LaValle, Parker Institute
• Janet Campbell, Epic
• Carlos Bifulco, Providence
• Elizabeth Mittendorf, Dana Farber Browse the current speaker list

130 showcase presentations by subject:
• AI & Data Sciences Showcase
• Clinical Dx Showcase
• Clinical and Research Tools Showcase
• Emerging Therapeutics Showcase
• Genomic Profiling Showcase
• Immunotherapy Showcase
• Liquid Biopsy Showcase
• Microbial Profiling Showcase

Don’t miss the opportunity to be part of this exquisite global gathering at The Premiere Precision Medicine Conference and learn first-hand about the industry’s recent research, technological, and clinical advancements, as well as cutting-edge new clinical applications and strategies that drive precision medicine and improve patient diagnosis, treatment, and outcomes. Meet in person with key opinion leaders and decision-makers are your perspective and help shape the future of precision medicine and its impact on health care.

Register Here for the Best Rates by December 12

I hope you will join us and I look forward to welcoming you at PMWC 2020 Silicon Valley!